Navigation Links
Milestone Scientific to Report 2008 Year-End Results on Tuesday, March 17, 2009
Date:3/17/2009

Investor Conference Call Scheduled for Thursday, March 19, 2009 at 11:00 AM ET

LIVINGSTON, N.J., March 17 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it intends to file its 2008 year-end results for the 12 months ended December 31, 2008 with the U.S. Securities & Exchange Commission on Tuesday, March 17, 2009.

Having succeeded in increasing sales for the award-winning STA Single Tooth Anesthesia System(TM) (STA System) for four consecutive quarters in 2008, the year-end results are expected to reflect record annual revenues of $6.62 million, up from $6.39 million in the prior year.

According to Joe Martin, Chief Executive Officer of Milestone, "The revised messaging and marketing platforms for the STA System that were implemented in early 2008 are now clearly resonating with dentists worldwide and attracting broad industry attention to our Company. Moreover, the clinical acclaim for the numerous tangible benefits of the STA System emanating from the dental community continues to inspire strong sales momentum. In addition, our decision to expand our distribution network from one exclusive distributor to numerous non-exclusive dental supply companies has resulted in much broader market penetration and a steady monthly increase in STA unit sales."

The Company will host a teleconference on Thursday, March 19, 2009, beginning at 11:00 AM Eastern Time, and invites all interested parties to join management in a discussion regarding Milestone's financial results, corporate progression and other meaningful developments. The conference call can be accessed by dialing toll-free 1-800-240-2430. For those unable to participate at that time, a replay of the teleconference can be accessed domestically by dialing 1
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pepscan Achieves First Milestone in Research Collaboration With Genmab
2. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
3. Heart Health Month Milestone: Half a Billion Pounds of Bad Fats Eliminated From North American Diet
4. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
5. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
6. Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials
7. CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
8. A Scientific Milestone: Sex of Dolphin at SeaWorld San Diego Determined Prior to Conception
9. Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
10. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
11. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that Dr. Pamela Pavco , ... the 23 rd World Congress of ... include in-depth presentations by world-class clinicians and/or ...
(Date:6/2/2015)... 02, 2015 Through rare discovery of ... Yancy Corporation is enabling World Scientists to actually ... biological sample, displaying the full nature (position, shape, size, ... , Jeff Porter, Co-Founder of the Yancy Corporation, says, ... – rare. They come once in a lifetime, if ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 Chosen ... health care, Jack Uldrich has been selected as ... New York today. He will deliver his keynote: ... Uldrich has delivered presentations to the American Medical ... Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, ...
(Date:6/1/2015)... and RARITAN, N.J. ... Development, LLC (Janssen) announced data from the Phase ... improvement in progression-free survival (PFS) with trabectedin (YONDELIS ... advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated ... chemotherapy regimen. SAR3007 is the largest randomized Phase ...
Breaking Biology Technology:RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... , CINCINNATI , June 3 Kendle ... organization (CRO), today announced it is ranked a top CRO ... Survey. Kendle is the only CRO to be ranked consistently ... four years in the annual U.S. and European site surveys ...
... June 3 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... Wolff , executive vice president and CFO, will provide an update on the ... business strategy at two investor conferences during the month of June: , ... The Jefferies 2010 ...
... June 3 The John Theurer Cancer Center ... that will be presented at the American Society of Clinical ... – 8, 2010 in Chicago . Research highlights include ... lymphoma, the efficacy and safety of a new genetically engineered ...
Cached Biology Technology:Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 2Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 3Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences 2New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting 2New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting 3New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting 4New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting 5New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting 6
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... , May 7, 2015 ... fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest touch ... FPC1035 are mainly considered for integration on the ... gives smartphone OEMs increased possibilities to integrate touch ... decreased size also improves possibilities for module manufacturers ...
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... reverse, reveals a new study published online on November 29th ... topi antelopes, females are the ones who aggressively pursue their ... view of sexual conflict holds that males, for whom reproducing ... other hand, females, who must pay a heftier price, are ...
... . How did the rodents which inhabited the ... The researcher of the UGR Raef Minwer-Barakat ... thesis "Rodents and insectivorous of Upper Turoliense and the Pliocene ... doctors Elvira Martn and Csar Viseras, of the Dept. ...
... in EMEA spurs IdentiPHI,s company ... expansion, ... security solutions and services, announces its,expansion with the opening of an office ... and authentication (access,management) products and solutions., "Opening the office in Europe ...
Cached Biology News:In promiscuous antelopes, the 'battle of the sexes' gets flipped 2Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 2IdentiPHI Opens Paris Office to Boost European Sales and Support 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: